116 related articles for article (PubMed ID: 4052953)
1. Effect of smoking on human natural killer cell activity.
Phillips B; Marshall ME; Brown S; Thompson JS
Cancer; 1985 Dec; 56(12):2789-92. PubMed ID: 4052953
[TBL] [Abstract][Full Text] [Related]
2. Reduction of natural killer cytotoxic activity in major depression: interaction between depression and cigarette smoking.
Jung W; Irwin M
Psychosom Med; 1999; 61(3):263-70. PubMed ID: 10367603
[TBL] [Abstract][Full Text] [Related]
3. Natural killer (NK) cell activity in patients with various malignancy against a variety of target cell lines: re-evaluation of clinical significance of natural killer cell activity.
Morikawa K; Nakano A; Oseko F; Morikawa S
Jpn J Med; 1989; 28(4):462-70. PubMed ID: 2810919
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic cell function in bronchogenic carcinoma.
Kratikanont P; deShazo RD; Banks DE; Chapman Y
Chest; 1987 Jul; 92(1):90-4. PubMed ID: 3595254
[TBL] [Abstract][Full Text] [Related]
6. Natural killer activity of peripheral blood lymphocytes and its relation to histopathological factors of lung cancer.
Terazawa A; Tanaka N; Senou N; Inoue F; Matsuura H; Gouchi A; Fuchimoto S; Mimura H; Orita K
Jpn J Surg; 1987 Jul; 17(4):236-42. PubMed ID: 3682431
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
8. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
LeFever AV; Funahashi A
Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
[TBL] [Abstract][Full Text] [Related]
9. Effect of smoking on natural killer cell activity in the lung.
Takeuchi M; Nagai S; Izumi T
Chest; 1988 Oct; 94(4):688-93. PubMed ID: 3262485
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell activity in cigarette smokers and asbestos workers.
Ginns LC; Ryu JH; Rogol PR; Sprince NL; Oliver LC; Larsson CJ
Am Rev Respir Dis; 1985 Jun; 131(6):831-4. PubMed ID: 4003932
[TBL] [Abstract][Full Text] [Related]
11. Role of natural killer cells in lung cancer.
Aktaş ON; Öztürk AB; Erman B; Erus S; Tanju S; Dilege Ş
J Cancer Res Clin Oncol; 2018 Jun; 144(6):997-1003. PubMed ID: 29616326
[TBL] [Abstract][Full Text] [Related]
12. Surface antigens and cytotoxic natural killer cell (NK) activity of blood lymphocytes in heavy cigarette smokers.
Jezewska E; Dworacki G; Skrzypczak A; Zeromski J
Arch Geschwulstforsch; 1990; 60(3):187-92. PubMed ID: 2369281
[TBL] [Abstract][Full Text] [Related]
13. Suppression of natural killer cell activity by surgical stress in cancer patients and the underlying mechanisms.
Yoshihara H; Tanaka N; Orita K
Acta Med Okayama; 1986 Apr; 40(2):113-9. PubMed ID: 2940814
[TBL] [Abstract][Full Text] [Related]
14. Diminished natural killer-cell activity of interstitial pulmonary cell populations from patients with carcinoma of the lung.
deShazo RD; Moulder PV; Bozelka B; Chapman Y
Chest; 1987 Jan; 91(1):26-8. PubMed ID: 3792080
[TBL] [Abstract][Full Text] [Related]
15. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with primary lung cancer.
Kim SK; Cho CH; Ahn CM; Jang SH; Lee YH; Kim SK; Chang J; Lee BK; Kim SJ; Youn JK
Yonsei Med J; 1992 Mar; 33(1):41-7. PubMed ID: 1502829
[TBL] [Abstract][Full Text] [Related]
16. Lung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma.
Pitchenik AE; Guffee J; Stein-Streilein J
Am Rev Respir Dis; 1987 Dec; 136(6):1327-32. PubMed ID: 3500659
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant drugs increase natural killer cell activity in lung cancer.
Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated killer cell activity in lung cancer.
LeFever A; Funahashi A
Chest; 1991 Feb; 99(2):292-7. PubMed ID: 1989785
[TBL] [Abstract][Full Text] [Related]
19. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
[TBL] [Abstract][Full Text] [Related]
20. [Effect of C-reactive protein on natural killer activity].
Shibuya M; Saijo N; Shimizu E; Taniguchi T; Takizawa T; Fujioka H; Hoshi A
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2341-6. PubMed ID: 6639096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
